Medpace Holdings, Inc. (MEDP) Average EV/Sales Ratio
The current ev/sales ratio for Medpace Holdings, Inc. (MEDP) is 4.74x as of Wednesday, June 17, 2026, shown against its trailing averages.
Average EV/Sales Ratio Chart
MEDP EV/Sales Ratio Averages
EV/SALES RATIO CURRENT
4.74x
EV/SALES RATIO TTM
6.02x
EV/SALES RATIO 3Y
5.55x
EV/SALES RATIO 5Y
5.39x
EV/SALES RATIO 10Y
4.69x
EV/SALES RATIO 15Y
4.69x
EV/SALES RATIO 20Y
4.69x
About Medpace Holdings, Inc.
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- August James Troendle